Clinical Outcomes in Multiple Myeloma Post-Autologous Transplantation—A Single Centre Experience-Reference-Cited by-同舟云学术

Clinical Outcomes in Multiple Myeloma Post-Autologous Transplantation—A Single Centre Experience

Published:2018-07-21 Issue:2 Volume:35 Page:215-222
ISSN:0971-4502
Container-title:Indian Journal of Hematology and Blood Transfusion
language:en
Short-container-title:Indian J Hematol Blood Transfus

Author:

Kulkarni Uday,Devasia Anup J.,Korula Anu,Fouzia NA,Nisham PN,Samoon Yasir J.,Lakshmi Kavitha M.,Abraham Aby,Srivastava Alok,Mathews Vikram,George Biju^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12288-018-0989-y.pdf

Reference18 articles.

1. Kyle RA, Rajkumar SV (2004) Multiple myeloma. N Engl J Med 351:1860–1873

2. Altekruse SF, Kosary CL, Krapcho M et al (2007) SEER cancer statistics review. Bethesda, National Cancer Institute

3. Miguel JFS (2015) Introduction to a series of reviews on multiple myeloma. Blood 125:3039–3040

4. Koreth J, Cutler CS, Djulbegovic B, Behl R, Schlossman RL, Munshi NC, Richardson PG, Anderson KC, Soiffer RJ, Alyea EP 3rd (2007) High-dose therapy with single autologous transplantation versus chemotherapy for newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials. Biol Blood Marrow Transpl 13(2):183–196

5. Tan D, Chng WJ, Chou T, Nawarawong W, Hwang SY, Chim CS, Chen W, Durie BG, Lee JH (2013) Management of multiple myeloma in Asia: resource-stratified guidelines. Lancet Oncol 14(12):e571–e581

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematopoietic cell transplantation landscape in India;Medical Journal Armed Forces India;2023-11

2. Bortezomib-based induction therapy followed by autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients: A single-center experience and review of Indian literature;Indian Journal of Cancer;2023-10

3. MCQs on Bortezomib-based induction therapy followed by autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients: A single-center experience and review of Indian literature;Indian Journal of Cancer;2023-10

4. Long-Term Outcomes of Autologous Hematopoietic Stem Cell Transplant (HSCT) for Multiple Myeloma: While New Horizons Emerge, It Is Still Only a Silver Lining for Resource-Constrained Settings;Cureus;2023-03-24

5. Autologous stem cell transplantation for multiple myeloma in the novel agent era: Systematic review of Indian data and implications for resource constrained settings;Journal of Cancer Research and Therapeutics;2023